التفاصيل البيبلوغرافية
العنوان: |
Additional file 1 of Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis |
المؤلفون: |
Chaoyuan Kuang (11917136), Yongseok Park (11917139), Ryan C. Augustin (11917142), Yan Lin (285018), Douglas J. Hartman (5095124), Lindsey Seigh (11917145), Reetesh K. Pai (11917148), Weijing Sun (8929409), Nathan Bahary (4405), James Ohr (11917151), John C. Rhee (11917154), Stanley M. Marks (11917157), H. Scott Beasley (11917160), Yongli Shuai (518858), James G. Herman (7479164), Hassane M. Zarour (9859083), Edward Chu (62482), James J. Lee (7725938), Anuradha Krishnamurthy (11917163) |
سنة النشر: |
2022 |
المجموعة: |
Smithsonian Institution: Digital Repository |
مصطلحات موضوعية: |
Medicine, Genetics, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Colorectal cancer, Mismatch repair proficient, Immunotherapy, DNA methyltransferase inhibitor, Epigenetic therapy, Azacitidine, Pembrolizumab, PD-1, PD-L1 |
الوصف: |
Additional file 1. Clinical trial protocol. |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
unknown |
العلاقة: |
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Pembrolizumab_plus_azacitidine_in_patients_with_chemotherapy_refractory_metastatic_colorectal_cancer_a_single-arm_phase_2_trial_and_correlative_biomarker_analysis/17982794Test |
DOI: |
10.6084/m9.figshare.17982794.v1 |
الإتاحة: |
https://doi.org/10.6084/m9.figshare.17982794.v1Test |
حقوق: |
CC BY + CC0 |
رقم الانضمام: |
edsbas.721079F |
قاعدة البيانات: |
BASE |